Search

Scientists at Sloan Kettering Institute have discovered that the α6ß4 integrin, one of several receptor proteins, plays a key role in signaling for the formation of new blood vessels for a tumor, a process called tumor angiogenesis. By blocking the signaling activity of the α6ß4 subunit of this integrin on vascular cells, researchers found they could slow the growth of tumors.

… Tuesday, February 8, 2005 Summary Scientists at Sloan Kettering Institute have discovered that the α6ß4 integrin, one of several receptor proteins, plays a key role in signaling for the formation of new blood vessels for a tumor, a process called tumor angiogenesis. By blocking the signaling activity

MSK surgeon James Eastham explains the pros and cons of PSA testing and weighs in on a new US Preventive Services Task Force guideline.

… Tuesday, April 11, 2017 Summary An MSK expert comments on a new US Preventive Services Task Force (USPSTF) guideline regarding a type of prostate cancer screening. The USPSTF has issued an updated guideline for prostate-specific-antigen-based screening for prostate cancer. The new guideline states that

Researchers have gained new understanding of how tumors metastasize by studying the behavior of exceptional breast and lung cancer cells that are capable of entering the brain and surviving there.

… Thursday, February 27, 2014 Summary Researchers have gained new understanding of how tumors metastasize by studying the behavior of exceptional breast and lung cancer cells that are capable of entering the brain and surviving there. Metastasis , the process that allows some cancer cells to break off

Combining checkpoint blockade with engineered T cells may lead to longer-lasting results in patients with breast cancer, lung cancer, and other solid tumors.

… Thursday, July 28, 2016 Summary Memorial Sloan Kettering is a leader in developing immunotherapies to treat cancer. Now researchers say combining two different immune approaches may better treat solid tumors. The immunotherapy treatment known as CAR T cell therapy , while still experimental, is showing

Cancers linked to HPV are on the rise. But only a little over half of all adolescents in the U.S. got the full series of vaccinations. In this Q&A, Chrisann Kyi talks about why it's so important for young people to get vaccinated.

… Thursday, September 27, 2018 Summary HPV-associated cancers are on the rise, but only about half of all adolescents in the United States have received the full series of shots. In this Q & A, Chrisann Kyi talks about why it’s so important for young people to get vaccinated. Update: On October 5, 2018

New research from Memorial Sloan Kettering Cancer Center (MSK) and the Sloan Kettering Institute explores ways to limit heart damage from chemotherapy and radiation; examines genomic differences between primary and metastatic tumors in bladder cancer; aims to understand the safety of check point inhibitor therapy for patients who are obese; and investigates a potential therapeutic approach against acute myeloid leukemia.

… Friday, December 23, 2022 New research from Memorial Sloan Kettering Cancer Center (MSK) and the Sloan Kettering Institute — MSK’s experimental research arm — explores ways to limit heart damage from chemotherapy and radiation; examines genomic differences between primary and metastatic tumors in bladder

Memorial Sloan Kettering Cancer Center (MSK) issued the following statement regarding its fiscal year 2022 financial results today.

… Friday, April 14, 2023 Memorial Sloan Kettering Cancer Center (MSK) issued the following statement regarding its fiscal year 2022 financial results today: MSK generated an operating loss of $248.1 million for fiscal year 2022, which was driven in large part by inflationary pressures that contributed

Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments.

… Friday, January 6, 2023 Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments: Lisa DeAngelis Lisa DeAngelis Honored by Society of Neuro-Oncology with Creation of Excellence in Education Award Lisa DeAngelis, MD, Physician-In-Chief, Chief Medical Officer, and Scott

Doctors at MSK Kids, the dedicated pediatric service at Memorial Sloan Kettering Cancer Center (MSK), pioneered many advances for pediatric patients in 2022.

… Monday, January 30, 2023 Doctors at MSK Kids , the dedicated pediatric service at Memorial Sloan Kettering Cancer Center (MSK), pioneered many advances for pediatric patients in 2022. A combination of clinical trial findings and laboratory studies contributed to a greater understanding of the role that

New MSK research developed a deep-learning model designed to aid challenging cancer diagnoses; identified key regulators of infection-clearing immune cells; and shed new light on the mechanical forces exerted by immune cells.

… Monday, July 8, 2024 New research from Memorial Sloan Kettering Cancer Center (MSK) developed a deep-learning model designed to aid challenging cancer diagnoses; identified key regulators of infection-clearing immune cells; and shed new light on the mechanical forces exerted by immune cells. MSK-developed